Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial Evaluating the Effect of Rosmarinus Officinalis Extract on Metabolic, Hepatic, Renal, Inflammatory, and Oxidative Stress Biomarkers in Patients With Type 2 Diabetes.

NCT07541729 is registered in ClinicalTrials.gov with Universidad Autonoma de Zacatecas as lead sponsor.

NCT NCT07541729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07541729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial Evaluating the Effect of Rosmarinus Officinalis Extract on Metabolic, Hepatic, Renal, Inflammatory, and Oxidative Stress Biomarkers in Patients With Type 2 Diabetes.
Lead sponsor
Universidad Autonoma de Zacatecas
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 20, 2025
Completion date
January 31, 2027
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation chronic, oxidative stress, type 2 diabetes mellitus (t2dm)